{"id":14383,"date":"2023-07-27T14:40:18","date_gmt":"2023-07-27T12:40:18","guid":{"rendered":"https:\/\/www.endoscopy-campus.com\/?post_type=ec-news&#038;p=14383"},"modified":"2023-07-27T14:40:19","modified_gmt":"2023-07-27T12:40:19","slug":"consider-endoscopic-upper-gi-screening-in-patients-with-head-and-neck-squamous-cell-cancer","status":"publish","type":"ec-news","link":"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/consider-endoscopic-upper-gi-screening-in-patients-with-head-and-neck-squamous-cell-cancer\/","title":{"rendered":"Consider Endoscopic Upper GI Screening in Patients With Head and Neck Squamous Cell Cancer"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">It is known that some patients with head and neck squamous cell carcinoma (HNSCC) can develop a second primary tumor (SPT). Timely detection of SPTs in an early stage through endoscopic screening could significantly enhance survival rates.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A prospective endoscopic screening study from the Netherlands included 202 patients with curably treated HNSCC diagnosed between January 2017 and July 2021. After their diagnosis, patients underwent synchronous (&lt;6 months) or metachronous (\u22656 months) screening, performed with flexible transnasal endoscopy and positron emission tomography and computed tomography scans or a magnetic resonance imaging scan. The primary outcome was the prevalence of SPTs, defined as the presence of esophageal high-grade dysplasia or squamous cell carcinoma.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">During synchronous and metachronous screenings, a total of 11 SPTs were detected in 10 patients, resulting in a prevalence of 5.0% (95% confidence interval, 2.4%-8.9%). Most SPTs were diagnosed in an early stage (90%) and treated with curative intent through endoscopic resection (80%). Routine imaging for HNSCC before the endoscopic screening did not detect any SPTs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>It is known that some patients with head and neck squamous cell carcinoma (HNSCC) can develop a second primary tumor (SPT). Timely detection of SPTs in an early stage through endoscopic screening could significantly enhance survival rates. A prospective endoscopic screening study from the Netherlands included 202 patients with curably treated HNSCC diagnosed between January &#8230; <a title=\"Consider Endoscopic Upper GI Screening in Patients With Head and Neck Squamous Cell Cancer\" class=\"read-more\" href=\"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/consider-endoscopic-upper-gi-screening-in-patients-with-head-and-neck-squamous-cell-cancer\/\" aria-label=\"Read more about Consider Endoscopic Upper GI Screening in Patients With Head and Neck Squamous Cell Cancer\">Read more<\/a><\/p>\n","protected":false},"template":"","categories":[1768,1791],"tags":[2098,3228,3227,3786,3787],"class_list":["post-14383","ec-news","type-ec-news","status-publish","hentry","category-asge-journal-scan","category-esophagus","tag-esophagus-2","tag-head-and-neck-squamous-cell-carcinoma","tag-hnscc","tag-second-primary-tumor","tag-spt"],"_links":{"self":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news\/14383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news"}],"about":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/types\/ec-news"}],"wp:attachment":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/media?parent=14383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/categories?post=14383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/tags?post=14383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}